Back
Cue Biopharma Vs. Cidara Therapeutics Industry Stock Comparison
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
Buy
62
CDTX
Cidara Therapeutics
Last Price:
14.66
Seasonality Move:
7.85%
Buy
54
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $14.48. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.50
The current trend is moderately bearish and CUE is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $14.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.94 | Buy |
| Chaikin Money Flow: | -441294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.75) | Sell |
| Bollinger Bands (100): | (0.58 - 1.36) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 75.01 | Buy |
| Chaikin Money Flow: | 12591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.1 - 13.56) | Buy |
| Bollinger Bands (100): | (11.03 - 12.91) | Buy |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Sell |
| 20-day SMA: | 1.62 | Sell |
| 50-day SMA: | 1.12 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.62 | Sell |
| 20-day EMA: | 1.54 | Sell |
| 50-day EMA: | 1.29 | Buy |
| 200-day EMA: | 1.47 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Buy |
| 20-day SMA: | 12.76 | Buy |
| 50-day SMA: | 11.74 | Buy |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 13.62 | Buy |
| 20-day EMA: | 12.9 | Buy |
| 50-day EMA: | 12.24 | Buy |
| 200-day EMA: | 13.18 | Buy |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Cue Biopharma Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||